[RRM1 expression in tissue microarray and prognosis analysis in non-small cell lung cancer]

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Context:

• Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide.
• Identifying reliable prognostic factors is crucial for effective patient management and treatment strategies in NSCLC.
• Ribonucleotide reductase M1 (RRM1) has been investigated as a potential prognostic marker in various cancers.

Purpose:

• To investigate the expression of RRM1 in NSCLC tissues.
• To evaluate the correlation between RRM1 expression and patient prognosis in NSCLC.
• To determine if RRM1 is an independent prognostic factor in NSCLC.

Summary:

• This study analyzed RRM1 expression in 417 NSCLC specimens using tissue microarray and immunohistochemistry.
• Results indicated no statistically significant difference in RRM1 expression across various clinical and pathological subgroups.
• Univariate and multivariate analyses concluded that RRM1 is not an independent prognostic factor in NSCLC.

Impact:

• This research clarifies the role of RRM1 as a prognostic marker in NSCLC, suggesting it is not a reliable indicator.
• The findings reinforce the importance of established prognostic factors, such as TNM staging, in NSCLC patient stratification.
• This study contributes to a better understanding of NSCLC prognostication, potentially guiding future research into more effective biomarkers.